Brief: CNS Pharmaceuticals Begins Manufacturing Of Berubicin In Europe

CNS Pharmaceuticals

09/10/2020 13:13

Oct 9 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS BEGINS MANUFACTURING OF BERUBICIN IN
EUROPE
    * CNS PHARMACEUTICALS INC - IMPLEMENTED A DUAL-TRACK DRUG
PRODUCT
MANUFACTURING STRATEGY
    * CNS PHARMACEUTICALS - ENGAGED 2 SEPARATE MANUFACTURERS FOR
BERUBICIN ON DIFFERENT CONTINENTS, BOTH PHARMACEUTICS
INTERNATIONAL, INC., BSP
    * CNS PHARMACEUTICALS INC - BSP AND PII HAVE NOW BEGUN
MANUFACTURING OF BERUBICIN
    * CNS PHARMACEUTICALS INC - EXPECTS TO COMPLETE
MANUFACTURING AT
BOTH LOCATIONS EARLY IN Q4

Source text for Eikon:  ID:nPn89zvv8a 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))